[Research progress on ferroptosis regulation in tumor immunity of hepatocellular carcinoma]
- PMID: 39694527
- PMCID: PMC11726010
- DOI: 10.3724/zdxbyxb-2024-0117
[Research progress on ferroptosis regulation in tumor immunity of hepatocellular carcinoma]
Abstract
Ferroptosis is a form of regulated cell death, which is dependent on iron metabolism imbalance and characterized by lipid peroxidation. Ferroptosis plays a crucial role in various pathological processes. Studies have shown that the occurrence of ferroptosis is closely associated with the progression of hepatocellular carcinoma (HCC). Ferroptosis is involved in regulating the lipid metabolism, iron homeostasis, mitochondrial metabolism, and redox processes in HCC. Additionally, ferroptosis plays a key role in HCC tumor immunity by modulating the phenotype and function of various immune cells in the tumor microenvironment, affecting tumor immune escape and progression. Ferroptosis-induced lipid peroxidation and oxidative stress can promote the polarization of M1 macrophages and enhance the pro-inflammatory response in tumors, inhibiting immune suppressive cells such as myeloid-derived suppressor cells and regulatory T cells to disrupt their immune suppression function. The regulation of expression of ferroptosis-related molecules such as GPX4 and SLC7A11 not only affects the sensitivity of tumor cells to immunotherapy but also directly influences the activity and survival of effector cells such as T cells and dendritic cells, further enhancing or weakening host antitumor immune response. Targeting ferroptosis has demonstrated significant clinical potential in HCC treatment. Induction of ferroptosis by nanomedicines and molecular targeting strategies can directly kill tumor cells or enhance antitumor immune responses. The integration of multimodal therapies with immunotherapy further expands the application of ferroptosis targeting as a cancer therapy. This article reviews the relationship between ferroptosis and antitumor immune responses and the role of ferroptosis in HCC progression from the perspective of tumor immune microenvironment, to provide insights for the development of antitumor immune therapies targeting ferroptosis.
铁死亡是一种依赖铁代谢失衡并以脂质过氧化为特征的调控性细胞死亡形式,在多种病理过程中发挥关键作用。研究表明,铁死亡的发生与肝细胞癌(HCC)的进展密切相关。铁死亡参与调控HCC的脂质代谢、铁离子稳态、线粒体代谢和氧化还原过程,在HCC肿瘤免疫中发挥着关键作用。铁死亡通过调节免疫微环境中不同细胞的表型和功能影响肿瘤的免疫逃逸和进展;铁死亡诱导的脂质过氧化物和氧化应激能促进M1型巨噬细胞的极化,增强肿瘤的促炎反应,同时抑制髓源性抑制细胞和调节性T细胞等免疫抑制细胞的功能,从而破坏免疫抑制;铁死亡相关分子如谷胱甘肽过氧化物酶4、溶质载体家族7成员11等的表达调控不仅影响肿瘤细胞对免疫治疗的敏感性,也直接作用于T淋巴细胞、树突状细胞等效应细胞的活性和生存,进一步增强或减弱抗肿瘤免疫反应。靶向铁死亡在HCC治疗中展现了重要的临床潜力,通过纳米医学和分子靶向策略诱导铁死亡,不仅直接杀伤肿瘤细胞,还能增强抗肿瘤免疫反应。结合免疫治疗的多模式疗法进一步拓展了铁死亡的应用。本文尝试从代谢调控和免疫细胞调节角度,探讨铁死亡在HCC进展中的作用,以期为开发基于铁死亡调控的综合抗肿瘤治疗策略提供新思路。.
Keywords: Ferroptosis; Hepatocellular carcinoma; Immune microenvironment; Immunotherapy; Review; Tumor immunity.
Conflict of interest statement
所有作者均声明不存在利益冲突
The authors declare that there is no conflict of interests
Similar articles
-
APE1 inhibition enhances ferroptotic cell death and contributes to hepatocellular carcinoma therapy.Cell Death Differ. 2024 Apr;31(4):431-446. doi: 10.1038/s41418-024-01270-0. Epub 2024 Feb 28. Cell Death Differ. 2024. PMID: 38418695 Free PMC article.
-
Silencing NRF2 enhances arsenic trioxide-induced ferroptosis in hepatocellular carcinoma cells.PLoS One. 2025 May 22;20(5):e0322746. doi: 10.1371/journal.pone.0322746. eCollection 2025. PLoS One. 2025. PMID: 40402956 Free PMC article.
-
Esculetin triggers ferroptosis via inhibition of the Nrf2-xCT/GPx4 axis in hepatocellular carcinoma.Chin J Nat Med. 2025 Apr;23(4):443-456. doi: 10.1016/S1875-5364(25)60853-3. Chin J Nat Med. 2025. PMID: 40274347
-
New perspectives on ferroptosis and its role in hepatocellular carcinoma.Chin Med J (Engl). 2022 Sep 20;135(18):2157-2166. doi: 10.1097/CM9.0000000000002327. Chin Med J (Engl). 2022. PMID: 36525603 Free PMC article. Review.
-
Ferroptosis in liver cancer: a key role of post-translational modifications.Front Immunol. 2024 Apr 8;15:1375589. doi: 10.3389/fimmu.2024.1375589. eCollection 2024. Front Immunol. 2024. PMID: 38650929 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical